These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 29495016)
21. Do recreational cannabis users, unlicensed and licensed medical cannabis users form distinct groups? Sznitman SR Int J Drug Policy; 2017 Apr; 42():15-21. PubMed ID: 28107687 [TBL] [Abstract][Full Text] [Related]
22. Psychometric properties of the CAST and SDS scales in young adult cannabis users. Cuenca-Royo AM; Sánchez-Niubó A; Forero CG; Torrens M; Suelves JM; Domingo-Salvany A Addict Behav; 2012 Jun; 37(6):709-15. PubMed ID: 22386300 [TBL] [Abstract][Full Text] [Related]
23. Measuring cannabis consumption: Psychometric properties of the Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU). Cuttler C; Spradlin A PLoS One; 2017; 12(5):e0178194. PubMed ID: 28552942 [TBL] [Abstract][Full Text] [Related]
24. A validation of the Cannabis Abuse Screening Test (CAST) using a latent class analysis of the DSM-IV among adolescents. Legleye S; Piontek D; Kraus L; Morand E; Falissard B Int J Methods Psychiatr Res; 2013 Mar; 22(1):16-26. PubMed ID: 23519957 [TBL] [Abstract][Full Text] [Related]
25. Are diagnostic orphans at risk of developing cannabis abuse or dependence? Four-year follow-up of young adult cannabis users not meeting diagnostic criteria. Degenhardt L; Coffey C; Carlin JB; Swift W; Patton GC Drug Alcohol Depend; 2008 Jan; 92(1-3):86-90. PubMed ID: 17716830 [TBL] [Abstract][Full Text] [Related]
26. The Marijuana Screening Inventory (MSI-X): reliability, factor structure, and scoring criteria with a clinical sample. Alexander DE; Leung P Am J Drug Alcohol Abuse; 2004 May; 30(2):321-51. PubMed ID: 15230079 [TBL] [Abstract][Full Text] [Related]
27. Validation of the French version of the Cannabis Use Disorder Identification Test-Revised and comparison with the Cannabis Abuse Screening Test for screening cannabis use disorder in a psychiatric sample. Luquiens A; Berger-Viergat A; Larrieu A; Artigaud L; Fener C; Adamson S; Laprévote V; Rolland B Drug Alcohol Rev; 2021 Nov; 40(7):1334-1339. PubMed ID: 33855757 [TBL] [Abstract][Full Text] [Related]
28. Revising the Cannabis Use Disorders Identification Test (CUDIT) by means of Item Response Theory. Annaheim B; Scotto TJ; Gmel G Int J Methods Psychiatr Res; 2010 Sep; 19(3):142-55. PubMed ID: 20812291 [TBL] [Abstract][Full Text] [Related]
29. Assessment of the validity of the CUDIT-R in a subpopulation of cannabis users. Loflin M; Babson K; Browne K; Bonn-Miller M Am J Drug Alcohol Abuse; 2018; 44(1):19-23. PubMed ID: 29058471 [TBL] [Abstract][Full Text] [Related]
30. Psychometric properties of CAST for early detection of problematic cannabis use in Spanish adolescents. Rial A; García-Couceiro N; Gómez P; Mallah N; Varela J; Flórez-Menéndez G; Isorna M Addict Behav; 2022 Jun; 129():107288. PubMed ID: 35219995 [TBL] [Abstract][Full Text] [Related]
31. Development and validation of the cannabis experiences questionnaire - Intoxication effects checklist (CEQ-I) short form. Quinn CA; Wilson H; Cockshaw W; Barkus E; Hides L Schizophr Res; 2017 Nov; 189():91-96. PubMed ID: 28189531 [TBL] [Abstract][Full Text] [Related]
32. Association between personality disorders traits and problematic cannabis use in adolescents. Chabrol H; Melioli T; Goutaudier N Subst Use Misuse; 2015 Apr; 50(5):552-6. PubMed ID: 25496169 [TBL] [Abstract][Full Text] [Related]
33. Reliability and validity of the Marijuana Motives Measure among young adult frequent cannabis users and associations with cannabis dependence. Benschop A; Liebregts N; van der Pol P; Schaap R; Buisman R; van Laar M; van den Brink W; de Graaf R; Korf DJ Addict Behav; 2015 Jan; 40():91-5. PubMed ID: 25240105 [TBL] [Abstract][Full Text] [Related]
34. Functioning of cannabis abuse and dependence criteria across two different countries: the United States and The Netherlands. Delforterie M; Creemers H; Agrawal A; Lynskey M; Jak S; van der Ende J; Verhulst F; Huizink A Subst Use Misuse; 2015 Jan; 50(2):242-50. PubMed ID: 25363693 [TBL] [Abstract][Full Text] [Related]
35. The influence of age and gender on the likelihood of endorsing cannabis abuse/dependence criteria. Delforterie MJ; Creemers HE; Agrawal A; Lynskey MT; Jak S; Huizink AC Addict Behav; 2015 Mar; 42():172-5. PubMed ID: 25481449 [TBL] [Abstract][Full Text] [Related]
36. Short scales to assess cannabis-related problems: a review of psychometric properties. Piontek D; Kraus L; Klempova D Subst Abuse Treat Prev Policy; 2008 Dec; 3():25. PubMed ID: 19055741 [TBL] [Abstract][Full Text] [Related]
37. The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: reliability, validity and diagnostic cut-off. Martin G; Copeland J; Gates P; Gilmour S Drug Alcohol Depend; 2006 Jun; 83(1):90-3. PubMed ID: 16310973 [TBL] [Abstract][Full Text] [Related]
38. Assessment of cannabis use disorders: a systematic review of screening and diagnostic instruments. López-Pelayo H; Batalla A; Balcells MM; Colom J; Gual A Psychol Med; 2015 Apr; 45(6):1121-33. PubMed ID: 25366671 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of the psychometric properties of the cannabis use disorders identification test - revised among college students. Schultz NR; Bassett DT; Messina BG; Correia CJ Addict Behav; 2019 Aug; 95():11-15. PubMed ID: 30798191 [TBL] [Abstract][Full Text] [Related]
40. The Cannabis Problems Questionnaire: factor structure, reliability, and validity. Copeland J; Gilmour S; Gates P; Swift W Drug Alcohol Depend; 2005 Dec; 80(3):313-9. PubMed ID: 15916867 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]